On June 9, 2008 ETHEX Corporation in coordination with the U.S. Food & Drug Administration (FDA) issued a nationwide voluntarily recall for a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an “ETHEX” label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall.
Resources
Morphine Recall - Learn more from drug side effect attorneys
Secure 128-bit SSL Encrypted Email Communication
